Binimetinib 15mg tablets
NHS hospitals in England used £20,496,640 of indicative cost of Binimetinib 15mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 17.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Binimetinib 15mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Binimetinib 15mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Oxford University Hospitals Nhs Ft | £1,539,840 |
| University Hospital Southampton Nhs Ft | £1,388,693 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,378,560 |
| Western Sussex Hospitals Nhs Found Trust | £929,387 |
| Lancashire T/Ing Hsp Nhs Foundation Trus | £757,120 |
| Maidstone And Tunbridge Wells Nhs Trust | £743,680 |
| Univ Hpls Bristol Nhs Foundation Trust | £716,427 |
| University Hpls Of Leicester Nhs Trust | £711,573 |
| The Clatterbridge Cancer Centre Nhs Ft | £695,813 |
| Univ Hpl B/Ham Nhs Foundation Trust | £681,840 |
The primary-care picture
Binimetinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Binimetinib medicine page.